StockData

Translational Development Acquisition Corp. (TDAC) stock

TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$10.88−0.01 (-0.05%)

Close on Nov 12, 2026Market cap $209.98MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026

Valuation

Market cap
$209.98M
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Net income
$5.54M

Trading

Previous close
$10.88
Open
$10.86
Day's range
$10.85 – $10.89
Volume
1,967
Average volume (20 days)
11,366
Beta (5 years)
-0.42
52-week range
$10.41 – $10.95
RSI (14 days)
55.8
Volatility (1 year)
2.6%
Relative volume
0.08×
WACC
7.4%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodTDACS&P 500DifferenceTDAC per yearS&P 500 per year
1 month+0.3%-2.7%+3.0 pts
3 months+0.2%-1.7%+2.0 pts
Year to date+3.7%+11.9%−8.2 pts
1 year+4.1%+12.0%−7.9 pts
3 years-28.2%+78.2%−106.3 pts-10.4%+21.2%
5 years-28.2%+73.2%−101.4 pts-6.4%+11.6%

Four years at a glance

Fiscal years 2022 to 2025 and trailing twelve months, USD

Operating income

-$1.32M

Net income

$5.54M+82.3% YoY
Reported periodTrailing twelve months

Press releases

Releases Translational Development Acquisition filed with the SEC as exhibits to Form 8-K or 6-K

  1. TDAC Announces ProLogium’s Filing of F-4 As Continuing Momentum
    News
  2. TDAC Announces Very Successful Share Redemption Results in Connection
    News
  3. a Next Generation Solid-State Battery Developer with 10+ Years of Proven
    Update
  4. 8-K exhibit EX-99.2
    Update
  5. Announces that the Separate Trading of its Class A Ordinary Shares and Warrants has Commenced
    News
  6. Independent Registered Public Accounting Firm
    News
All press releases and earnings

About Translational Development Acquisition

Blank Checks

The entity operates as a blank check company formed to execute a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with an operating business. Because the organization functions as an investment vehicle, it does not manufacture commercial products, provide direct services, or maintain distinct business segments. In addition, the firm does not serve traditional commercial customers. Instead, its activities center on identifying, evaluating, and selecting prospective target entities that possess competitive advantages and growth potential.

Company profile, executives and history

Translational Development Acquisition stock: common questions

What is Translational Development Acquisition's stock price?

TDAC closed at $10.88 on Nov 12, 2026, down 0.05% on the day. Over the past 52 weeks it traded between $10.41 and $10.95.

What is Translational Development Acquisition's market cap?

Translational Development Acquisition was worth $209.98M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

Does Translational Development Acquisition pay a dividend?

No. Translational Development Acquisition has not paid a cash dividend over the last twelve months.

How has TDAC stock performed over the past year?

Including dividends, TDAC returned +4.1% over the past year, against +12.0% for the S&P 500.

Who are Translational Development Acquisition's competitors?

Companies most similar to Translational Development Acquisition by business, industry and size include SDHI, TACO, ALDFF, SBXDF, QUMS.

See a number that looks wrong?